Skip to content

Assessment of Early Pregnancy MAB Completion

Assessing Completion of Medication Abortion for Very Early Pregnancies

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06893484
Enrollment
400
Registered
2025-03-25
Start date
2025-03-13
Completion date
2026-06-01
Last updated
2026-05-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abortion Early, Pregnancy

Keywords

very early pregnancy, pregnancy test

Brief summary

This is a prospective study to evaluate if successful completion of a medication abortion in patients with very early pregnancy can be detected with a urine pregnancy test at 2 weeks instead of 4 weeks. Additionally, the resolution of pregnancy symptoms in these patients will be characterized. Enrolled participants will take take weekly pregnancy tests and complete weekly questionnaires on their pregnancy symptoms for 4 weeks after their medication abortion.

Interventions

DIAGNOSTIC_TESTWeekly high-sensitivity urine pregnancy tests

Participants will take a high-sensitivity urine pregnancy test at home weekly for up to 4 weeks compared to the taking just one home urine pregnancy test at 4-5 weeks. Participants will also complete short weekly questionnaires on their pregnancy symptoms and follow-up care.

Sponsors

University of Washington
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
No

Inclusion criteria

* Pregnant person with early pregnancy ≤42 days * Eligible and consented to a medication abortion * Have access to receiving text messages and the internet * Able to read and understand English

Exclusion criteria

\- Privacy or safety concerns about filling out the surveys

Design outcomes

Primary

MeasureTime frameDescription
Proportion of participants with negative high-sensitivity urine pregnancy test at 2 weeksFrom time of taking Mifepristone to negative pregnancy test or 4-5 weeks of questionnairesTo estimate the proportion of negative high-sensitivity urine pregnancy tests in participants with very early pregnancy and a complete abortion at 2 weeks after taking Mifepristone and compare this proportion to the proportion of negative high-sensitivity urine pregnancy tests in participants with very early pregnancy and a complete abortion at 4 weeks

Secondary

MeasureTime frameDescription
Time to resolution of pregnancy symptomsFrom time of taking Mifepristone to negative pregnancy test or 4-5 weeks of questionnairesTo compare the timing of pregnancy symptom resolution per patient report on weekly questionnaires with the timing of a negative high-sensitivity urine pregnancy test result

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORLyndsey Benson, MD, MS

University of Washington

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 9, 2026